COST Action: INTercEption of oRal CancEr develoPmenT - INTERCEPT

Datos básicos

Código del Financiador:

EU24/28

Año Inicial:

2024

Año final:

2026

Objetivos del proyecto

The INTERCEPT (INTercEption of oRal CancEr develoPmenT) COST Action addresses the challenge of unmet oral cancer prevention and bring new paradigm to disease management of oral potentially malignant disorders (OPMD). Relying on excellent translational research, patient care and education in Europe (EU) in the field of cancer medicine, INTERCEPT will develop future strategies of personalized OPMD preventive and care approaches. Pluridisciplinary expertise will involve and target a spectrum of keys actors to ensure a long-term success.